Adam Bass had recently founded Columbia University’s Center for Precision Cancer Medicine, after spending ten years translating new oncology science to the clinic at the Dana-Farber Cancer Institute and Harvard, as leader of the Gastrointestinal Malignancies Program.  He was also enjoying his work with the Broad Institute.  Then Novartis’s Institute for BioMedical Research called, and he settled to become its Global Head of Oncology Translational Research. Adam has always liked to push the boundaries. After college, he and his friends turned a 1960’s school bus into an RV and drove as far West as they could.  The bus broke down in the middle of Utah, but the trip was great.

‍